These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 4119747

  • 1. Sustained-release levodopa in parkinsonism.
    Eckstein B, Shaw K, Stern G.
    Lancet; 1973 Feb 24; 1(7800):431-2. PubMed ID: 4119747
    [No Abstract] [Full Text] [Related]

  • 2. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH.
    Neurology; 1970 Dec 24; 20(12):31-5. PubMed ID: 4924342
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD.
    Neurology; 1970 Dec 24; 20(12):Suppl:6-13. PubMed ID: 4921587
    [No Abstract] [Full Text] [Related]

  • 8. L-dopa in idiopathic parkinsonism.
    Calne DB, Stern GM, Spiers AS, Laurence DR.
    Lancet; 1969 Nov 08; 2(7628):973-6. PubMed ID: 4186975
    [No Abstract] [Full Text] [Related]

  • 9. Effect of age and arteriosclerosis on the response of Parkinsonian patients to levodopa.
    Godwin-Austen RB, Bergmann S, Frears CC.
    Br Med J; 1971 Nov 27; 4(5786):522-4. PubMed ID: 4942463
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sustained levodopa therapy in parkinsonism.
    Hunter KR, Shaw KM, Laurence DR, Stern GM.
    Lancet; 1973 Oct 27; 2(7835):929-31. PubMed ID: 4126558
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ, Somerville B.
    Med J Aust; 1974 Mar 23; 1(12):429-32. PubMed ID: 4598384
    [No Abstract] [Full Text] [Related]

  • 19. The treatment of parkinsonism with levodopa.
    Sutcliffe RL.
    Gerontol Clin (Basel); 1974 Mar 23; 16(1):151-6. PubMed ID: 4855131
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of Parkinsonism with Laevo-dopa.
    Mawdsley C.
    Br Med J; 1970 Feb 07; 1(5692):331-7. PubMed ID: 4906702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.